Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 33.65
+0.05 (0.15%)
At close: Sep 23, 2026
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.33 billion as of September 23, 2026. Its market cap has decreased by -37.60% in one year.
Market Cap
3.33B
Enterprise Value
2.65B
Revenue
62.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
33.65
ChartMarket Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.33B, an increase of 11.63%. That is a compound annual growth rate of 2.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.33B | -31.67% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 3.46B |
| Shanghai Shen Lian Biomedical | 3.42B |
| Landfar Bio-medicine | 3.30B |
| Jiangsu Bioperfectus Technologies | 3.13B |
| Qingdao Vland Biotech INC. | 3.10B |
| Guanhao Biotech | 2.98B |
| Baolingbao Biology | 2.93B |
| Beijing Kawin Technology Share-Holding | 2.88B |